ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SGMT vs ANNX // DIVIDEND YIELD & FCF PAYOUT SAFETY

Sagimet Biosciences Inc. (Series A) (NASDAQ) VS. Annexon Inc. (NASDAQ) • 15-METRIC TALLY: SGMT 1 — ANNX 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGMT VS. ANNX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SGMT ANNX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.21% -24.53% +18.32 SGMT /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.3 52.4 -0.10 ANNX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $699.7M $767.8M -$68.1M ANNX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SGMT REV ANNX REV SGMT GROSS % ANNX GROSS % SGMT FCF ANNX FCF
FY 2025 $159.3M $605.9M — — -$45.6M -$186.5M
FY 2024 $152.5M $431.4M — — -$42.4M -$118.0M
FY 2023 $2.0M $402.4M — — -$23.8M -$121.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGMT // BETA —
ANNX // BETA —